Abstract. The main purpose of this work is to investigate the qualitative behavior of an HIV dynamics model with two types of cocirculating target cells. The model takes into account both short-lived and long lived chronically infected cells. In the two types of target cells, the drug efficacy is assumed to be different. The incidence rate is represented by Crowley-Martin functional response. First we have derived the basic reproduction number R 0 , then constructed Lyapunov functions to establish the global asymptotic stability of the disease-free and endemic equilibria of the model. We have been proven that, the disease-free equilibrium is globally asymptotically stable (GAS) when R 0 Ä 1, and the endemic equilibrium is GAS when R 0 > 1. Numerical simulations have been carried out to support our theoretical results.
INTRODUCTION
Although the mathematical modeling of human immunodeficiency virus (HIV) dynamics alone cannot deals with issues associated with HIV infection, it can be a helpful tool for a good understanding the viral dynamics in vivo. Mathematical models can improved strategies of diagnosis and treatment. Today, many anti-HIV drugs are available for patients with HIV, which led to a rapid decrease in viruses and an increase in the major target cells of the virus, CD4 C T cells. There are two main categories of anti-HIV, the reverse-transcriptase inhibitors RTIs drugs which prevent HIV from infecting the target cells, and the protease inhibitors PIs drugs which prevent the infected cells from producing new infectious viruses [1] . In the literature, several mathematical models describing the HIV dynamics in vivo have been proposed (see, e.g. [3] , [6] [7] [8] [9] [10] , [12, 13] ). However, these models did not take into account the difference between short-lived infected cells and long lived chronically infected cells. In HIV infection, the short-lived infected cells produce much larger amounts of viruses than long lived chronically infected cells and die at a much faster rate [2] . The basic HIV infection model which takes into account long lived chronically infected cells under the effect of antiviral drug therapy has been proposed in [2] as: where x; y;´and v represent, respectively, the concentrations of the uninfected CD4 C T cells, short-lived infected cells, long lived chronically infected cells, and free viruses. Parameters and d are the birth rate and death rate constants of the uninfected CD4 C T cells. Parameter Ň is the infection rate constant. The short-lived infected CD4 C T cells, long lived chronically infected CD4 C T cells and free viruses are die with rate constants ı, a and u; respectively. The fractions .1 q/ and q with 0 < q < 1 are the probabilities during the infection on which an uninfected cell will become either short-lived infected or long lived chronically infected. Parameters N and M are the average number of virus particles generated in the lifetime of the short-lived infected and long lived chronically infected cells, respectively. The model incorporates RTI drug therapy with drug efficacy denoted by " and 0 Ä " Ä 1: All the parameters mentioned in the model are positive. In a very recent work [8] , model (1.1)-(1.4) has been modified to consider the antibody immune response. In model (1.1)-(1.4), it was assumed that, the HIV has one class of target cells, CD4 C T cells. Based on the observation of Perelson et al. [9] that, the HIV attack two types of cells CD4 C T cells and macrophages. Recently, many efforts have been devoted to propose and analyze various mathematical models of HIV dynamics with two classes of target cells [2, 5, 6, 8, 10] In [4] , the virus dynamics models have been studied by assuming that the virus has multiple classes of uninfected target cells. However, in [5, 6, 8, 10] and [4] , only short-lived infected cells has been considered. In [2] , the model (1.1)-(1.4) was extended to take into consideration two cocirculating target cells, CD4 C T cells and macrophages as:
where x i ; y i ;´i ; and v denote the concentrations of uninfected target cells, short-lived infected cells, long lived chronically infected cells, and free viruses, respectively, and i D 1; 2 correspond to the CD4 C T cells and macrophages, respectively. In the CD4 C T cells, the drug efficacy is " while in the macrophages the drug efficacy is "f reduced by a factor f where 0 < f < 1. The definitions of all parameters and variables are identical to those given in Eqs. (1.1)-(1.4).
We have observed that, the qualitative behavior of model (1.5)-(1.11) are not studied in the literature. Moreover, in model (1.5)-(1.11), the incidence rate between the uninfected target cells and viruses is given by bilinear, i.e., the infection rate per virus and per uninfected cell is constant. However, this bilinear incidence rate may not completely describe the infection process. Therefore, several forms of the incidence rate have been proposed, such as saturated incidence rate,ˇx [13] . Our primary goal of the present paper is to propose an HIV dynamics model with two types of cocirculating target cells, CD4 C T cells and macrophages and investigate its qualitative behavior. In the two types of target cells, the drug efficacy is assumed to be different. Both short-lived and long lived chronically infected cells are considered in the mathematical model. The incidence rate is represented by by Crowley-Martin functional response. The global stability of all equilibria of the model is established using direct Lyapunov method. The basic reproduction number R 0 of the model is derived. We have established that, the disease-free equilibrium is globally asymptotically stable (GAS) when R 0 Ä 1, and the endemic equilibrium is GAS when R 0 > 1.
THE MODEL
In this section, we introduce a mathematical model of HIV dynamics which describes two cocirculation populations of target cells, CD4 C T cells and macrophages taking into account both of short-lived and long lived chronically infected cells. The model is more general than model (1.5)-(1.11) by assuming that the incidence rate of infection is given by Crowley-Martin functional response and the parameter ı; a; q; N and M for the CD4 C T cells and macrophages are not identically.
where i ,˛i , i D 1; 2 are positive constants and all the parameters and variables of the model have the same meanings as given in (1.
THE ANALYSIS OF THE MODEL
One can easily show the positive invariance of the non-negative orthant R 7 0 for model (2.1)-(2.4) (see e.g. [6] and [10] ).
Proof. To show the boundedness of the solutions of system (2.
. Since 
Proof. The equilibria of model (2.1)-(2.4) satisfy the following equations:
From Eqs. (3.2) and (3.3) we have
Inserting y i and´i into Eq. (3.4) we obtain
Equation (3.6) has two possible solutions
If v D 0 then substituting it in Eqs. (3.1) and (3.5), leads to a disease-free equilibrium E 0 D .x 
From Eqs. (3.1), (3.4) and (3.5) we get
Since x i is a function of v, then we can define a function H.v/ as:
Now
Since H.v/ is continuous for all v 0, we have that
Therefore, if 
Now, we are ready to define the parameter R 0 as:
where, R 01 represents the basic infection reproduction number of the HIV dynamics with CD4 C T cells (in the absence of macrophages) and R 02 represents the basic infection reproduction number of the HIV dynamics with macrophages (in the absence of CD4 C T cells), respectively. The parameter R 0 determines whether the infection can be established.
Here, we establish the global stability of the two equilibria of system (2.1)-(2.4) employing the direct Lyapunov method and LaSalle's invariance principle. The following function will be used throughout the paper F W .0; 1/ ! OE0; 1/ as:
Theorem 1. The disease-free equilibrium E 0 of system (2.1)-(2.4) is GAS when R 0 Ä 1:
Proof. Define Lyapunov functional W 0 as:
We calculate
along the trajectories of system of (2.1)-(2.4) as:
Collecting terms of Eq. (3.11) we get Proof. We consider the Lyapunov functional W 1 as:
along the solutions of system (2.1)-(2.4) we obtain
Collecting terms of Eq. (3.13) we get
Using the equilibrium conditions for E 1 :
and the following equality
we obtain
(3.14)
Eq. (3.14) can be rewritten as:
Because the geometrical mean is less than or equal to the arithmetical mean, then the last two terms of Eq. The parameter " will be chosen below:
(i) R 0 Ä 1: Let " D 0:98; then we get R 0 D 0:88. According to Theorem 1, E 0 is GAS. Figures 1-7 show that the numerical results are compatible with the results of Theorem 1. We can see that, the concentrations of uninfected CD4 C T cells and macrophages are increasing and converge to their normal values
D 600, respectively, while the concentrations of infected cells and free viruses are decaying and tend to zero. In this case, the treatment succeeded to eliminate the viruses from the blood.
(ii) R 0 > 1: We choose " D 0; then we compute R 0 D 4:73: From Figures 1-7 we can see that, our simulation results are consistent with the theoretical results of Theorem 2, where is E 1 GAS. We can observe that, the trajectory of system (2.1)-(2.4) converges to E 1 D .630:16; 3:69; 6:16; 300:38; 4:99; 14:98; 38:97/: We note that, when " D 0, i.e. there is no treatment the infection becomes chronic. long lived chronically infected cells have been taken into account. The infection rate is given by Crowley-Martin functional response. The global stability of the diseasefree equilibrium and endemic equilibrium of the model has been established by constructing suitable Lyapunov functionals and using LaSalle's invariant principle. We have derived the basic infection reproduction number R 0 for the model. We have proven that, the disease-free equilibrium E 0 is GAS when R 0 Ä 1, and the endemic equilibrium E 1 is GAS when R 0 > 1.
